Bismatrol
- Product NDC
- 0904-1313
- Requested package NDC
- 0904-1313-09
- 11-digit product format
- 009041313
- Labeler code
- 0904
- Product ID
- 0904-1313_332a78df-80f8-45aa-91a3-dc762b8bc8a3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bismuth Subsalicylate
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Major Pharmaceuticals
- Application
- part335
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2008-05-30
- Marketing end
- 2021-02-28
- Substance
- BISMUTH SUBSALICYLATE
- Active strength
- 262 mg/15mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0904-1313 | 0904-1313-09 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15 | Product name | 1 | 20240313 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-1313-09 | ML - Milliliter | 0904-1313 | 56076192-e0b3-49bb-ba2d-88b6f259e9c2 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308762 | bismuth subsalicylate 525 MG in 30 mL Oral Suspension | PSN | a266f599-2f2c-416f-9ef9-a1d3db552c89 | 7 |
| 308762 | bismuth subsalicylate 17.5 MG/ML Oral Suspension | SCD | a266f599-2f2c-416f-9ef9-a1d3db552c89 | 7 |
| 308762 | bismuth subsalicylate 1.75 % Oral Suspension | SY | a266f599-2f2c-416f-9ef9-a1d3db552c89 | 7 |
| 308762 | bismuth subsalicylate 262 MG per 15 ML Oral Suspension | SY | a266f599-2f2c-416f-9ef9-a1d3db552c89 | 7 |
| 308762 | bismuth subsalicylate 524 MG per 30 ML Oral Suspension | SY | a266f599-2f2c-416f-9ef9-a1d3db552c89 | 7 |
| 308762 | bismuth subsalicylate 525 MG per 30 ML Oral Suspension | SY | a266f599-2f2c-416f-9ef9-a1d3db552c89 | 7 |
| 308762 | bismuth subsalicylate 525 MG in 30 mL Oral Suspension | PSN | c99c1061-baa4-4c0f-bbae-3d1eea43a6a5 | 2 |
| 308762 | bismuth subsalicylate 17.5 MG/ML Oral Suspension | SCD | c99c1061-baa4-4c0f-bbae-3d1eea43a6a5 | 2 |
| 308762 | bismuth subsalicylate 1.75 % Oral Suspension | SY | c99c1061-baa4-4c0f-bbae-3d1eea43a6a5 | 2 |
| 308762 | bismuth subsalicylate 262 MG per 15 ML Oral Suspension | SY | c99c1061-baa4-4c0f-bbae-3d1eea43a6a5 | 2 |
| 308762 | bismuth subsalicylate 524 MG per 30 ML Oral Suspension | SY | c99c1061-baa4-4c0f-bbae-3d1eea43a6a5 | 2 |
| 308762 | bismuth subsalicylate 525 MG per 30 ML Oral Suspension | SY | c99c1061-baa4-4c0f-bbae-3d1eea43a6a5 | 2 |
| 308762 | bismuth subsalicylate 525 MG in 30 mL Oral Suspension | PSN | 6b4d6e96-4d67-43cd-b4ff-8d02e80e0b3c | 1 |
| 308762 | bismuth subsalicylate 17.5 MG/ML Oral Suspension | SCD | 6b4d6e96-4d67-43cd-b4ff-8d02e80e0b3c | 1 |
| 308762 | bismuth subsalicylate 1.75 % Oral Suspension | SY | 6b4d6e96-4d67-43cd-b4ff-8d02e80e0b3c | 1 |
| 308762 | bismuth subsalicylate 262 MG per 15 ML Oral Suspension | SY | 6b4d6e96-4d67-43cd-b4ff-8d02e80e0b3c | 1 |
| 308762 | bismuth subsalicylate 524 MG per 30 ML Oral Suspension | SY | 6b4d6e96-4d67-43cd-b4ff-8d02e80e0b3c | 1 |
| 308762 | bismuth subsalicylate 525 MG per 30 ML Oral Suspension | SY | 6b4d6e96-4d67-43cd-b4ff-8d02e80e0b3c | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0904-1313-09 | 00904131309 | 236 mL in 1 BOTTLE (0904-1313-09) | 236 ml | 2008-05-30 | 2021-02-28 | No | No | Current |